809 related articles for article (PubMed ID: 1967512)
1. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Balkau B; Eschwège E; Poupon R
N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
[TBL] [Abstract][Full Text] [Related]
4. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
6. Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis.
Crippa G; Cagnoni C; Castelli A; Concesi C; Girometta S; Pancotti D; Sverzellati E; Tacchini G; Pierfranceschi MG; Carrara GC
Clin Ter; 1995 May; 146(5):367-72. PubMed ID: 7796569
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease.
Kneppelhout JC; Mulder CJ; van Berge Henegouwen GP; de Vries RA; Brandt KH
Neth J Med; 1992 Aug; 41(1-2):11-6. PubMed ID: 1407234
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
Poupon RE; Eschwège E; Poupon R
J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
[TBL] [Abstract][Full Text] [Related]
9. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Schalm SW
Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
Batts KP; Jorgensen RA; Dickson ER; Lindor KD
Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurov FKh
Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
14. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD
Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252
[TBL] [Abstract][Full Text] [Related]
15. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
16. [Ursodeoxycholic acid therapy in biliary cirrhosis].
Herszényi L; Szalay L; Schaff Z; Gergely P; Fehér J
Orv Hetil; 1993 Sep; 134(38):2085-9. PubMed ID: 8414454
[TBL] [Abstract][Full Text] [Related]
17. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
[TBL] [Abstract][Full Text] [Related]
18. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
Leevy CB; Holt J; Buniak B
J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
